VivoSeq
Other

Clozapine-Induced Hypersalivation

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Clozapine-induced Hypersalivation is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

4

clinical trials

Completed4 · 100%

Clinical Trials

Trial Activity

Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
Completed·CCentre for Addiction and Mental Health·N/A·NCT00381589·25 enrolled
Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation
Completed·—·Phase 3·NCT00534573·54 enrolled
Metoclopramide as Treatment of Clozapine-induced Hypersalivation
Completed·—·Phase 3·NCT02222220·61 enrolled
Clozapine-induced Hypersalivation - Feasibility Trial
Completed·MMersey Care NHS Trust·Phase 1/2·NCT02613494·29 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)